玛丽·布罗德富特·沃克（1888 - 1974）。 - Suppr

Suppr

超能文献

Mary Broadfoot Walker (1888-1974).

作者信息

Johnston J D

机构信息

Medicines and Healthcare products, Regulatory Agency, Floor 11, Market Towers, 1 Nine Elms Lane, London SW8 5NQ, UK.

出版信息

J Neurol. 2007 Sep;254(9):1306-7. doi: 10.1007/s00415-007-0663-z.

DOI:10.1007/s00415-007-0663-z

PMID:18000738

Abstract

摘要

相似文献

Mary Broadfoot Walker (1888-1974).

J Neurol. 2007 Sep;254(9):1306-7. doi: 10.1007/s00415-007-0663-z.

Mary Broadfoot Walker: 83 years since a historical discovery.

Arq Neuropsiquiatr. 2017 Nov;75(11):825-826. doi: 10.1590/0004-282X20170138.

Contemporary opinions about Mary Walker: a shy pioneer of therapeutic neurology.

Neurology. 1998 Nov;51(5):1433-9. doi: 10.1212/wnl.51.5.1433.

Dr Lazar Remen (1907-74): a forgotten pioneer in the treatment of myasthenia gravis.

J Med Biogr. 2009 May;17(2):73-4. doi: 10.1258/jmb.2009.009003.

The Mary Walker effect: Mary Broadfoot Walker.

J R Coll Physicians Edinb. 2019 Sep;49(3):255-259. doi: 10.4997/JRCPE.2019.317.

Mary Broadfoot Walker (1888-1974): a historic discovery in myasthenia gravis.

Eur Neurol. 2005;53(1):51-3. doi: 10.1159/000084268. Epub 2005 Mar 1.

Mary B. Walker, M.D. and the pioneering use of prostigmin to treat myasthenia gravis.

Doc Ophthalmol. 1997;93(1-2):125-34. doi: 10.1007/BF02569052.

The miracle at St Alfege's: seventy years on.

J R Soc Med. 2007 Feb;100(2):108-9. doi: 10.1177/014107680710000230.

The history of acetylcholinesterase inhibitors in the treatment of myasthenia gravis.

Neuropharmacology. 2021 Jan;182:108303. doi: 10.1016/j.neuropharm.2020.108303. Epub 2020 Sep 9.

The contribution of Dr. Mary Walker towards myasthenia gravis and periodic paralysis whilst working in poor law hospitals in London.

J Hist Neurosci. 2005 Jun;14(2):121-37. doi: 10.1080/096470490512580.

引用本文的文献

Reversal of experimental paralysis in a human by intranasal neostigmine aerosol suggests a novel approach to the early treatment of neurotoxic envenomation.

Clin Case Rep. 2013 Oct;1(1):7-15. doi: 10.1002/ccr3.3. Epub 2013 Jul 24.

本文引用的文献

Myasthenia Gravis: A Case in which Fatigue of the Forearm Muscles could induce Paralysis of the Extra-ocular Muscles.

Proc R Soc Med. 1938 May;31(7):722. doi: 10.1177/003591573803100709.

Case showing the Effect of Prostigmin on Myasthenia Gravis.

Proc R Soc Med. 1935 Apr;28(6):759-61. doi: 10.1177/003591573502800633.

The contribution of Dr. Mary Walker towards myasthenia gravis and periodic paralysis whilst working in poor law hospitals in London.

J Hist Neurosci. 2005 Jun;14(2):121-37. doi: 10.1080/096470490512580.

Contemporary opinions about Mary Walker: a shy pioneer of therapeutic neurology.

Neurology. 1998 Nov;51(5):1433-9. doi: 10.1212/wnl.51.5.1433.

Some discoveries on myasthenia gravis: the background.

Br Med J. 1973 Apr 7;2(5857):42-3. doi: 10.1136/bmj.2.5857.42.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Mary Broadfoot Walker (1888-1974).

作者信息

Johnston J D

机构信息

Medicines and Healthcare products, Regulatory Agency, Floor 11, Market Towers, 1 Nine Elms Lane, London SW8 5NQ, UK.

出版信息

J Neurol. 2007 Sep;254(9):1306-7. doi: 10.1007/s00415-007-0663-z.

DOI:10.1007/s00415-007-0663-z

PMID:18000738

Abstract

摘要

相似文献

Mary Broadfoot Walker (1888-1974).

J Neurol. 2007 Sep;254(9):1306-7. doi: 10.1007/s00415-007-0663-z.

Mary Broadfoot Walker: 83 years since a historical discovery.

Arq Neuropsiquiatr. 2017 Nov;75(11):825-826. doi: 10.1590/0004-282X20170138.

Contemporary opinions about Mary Walker: a shy pioneer of therapeutic neurology.

Neurology. 1998 Nov;51(5):1433-9. doi: 10.1212/wnl.51.5.1433.

Dr Lazar Remen (1907-74): a forgotten pioneer in the treatment of myasthenia gravis.

J Med Biogr. 2009 May;17(2):73-4. doi: 10.1258/jmb.2009.009003.

The Mary Walker effect: Mary Broadfoot Walker.

J R Coll Physicians Edinb. 2019 Sep;49(3):255-259. doi: 10.4997/JRCPE.2019.317.

Mary Broadfoot Walker (1888-1974): a historic discovery in myasthenia gravis.

Eur Neurol. 2005;53(1):51-3. doi: 10.1159/000084268. Epub 2005 Mar 1.

Mary B. Walker, M.D. and the pioneering use of prostigmin to treat myasthenia gravis.

Doc Ophthalmol. 1997;93(1-2):125-34. doi: 10.1007/BF02569052.

The miracle at St Alfege's: seventy years on.

J R Soc Med. 2007 Feb;100(2):108-9. doi: 10.1177/014107680710000230.

The history of acetylcholinesterase inhibitors in the treatment of myasthenia gravis.

Neuropharmacology. 2021 Jan;182:108303. doi: 10.1016/j.neuropharm.2020.108303. Epub 2020 Sep 9.

The contribution of Dr. Mary Walker towards myasthenia gravis and periodic paralysis whilst working in poor law hospitals in London.

J Hist Neurosci. 2005 Jun;14(2):121-37. doi: 10.1080/096470490512580.

引用本文的文献

Reversal of experimental paralysis in a human by intranasal neostigmine aerosol suggests a novel approach to the early treatment of neurotoxic envenomation.

Clin Case Rep. 2013 Oct;1(1):7-15. doi: 10.1002/ccr3.3. Epub 2013 Jul 24.

本文引用的文献

Myasthenia Gravis: A Case in which Fatigue of the Forearm Muscles could induce Paralysis of the Extra-ocular Muscles.

Proc R Soc Med. 1938 May;31(7):722. doi: 10.1177/003591573803100709.

Case showing the Effect of Prostigmin on Myasthenia Gravis.

Proc R Soc Med. 1935 Apr;28(6):759-61. doi: 10.1177/003591573502800633.

The contribution of Dr. Mary Walker towards myasthenia gravis and periodic paralysis whilst working in poor law hospitals in London.

J Hist Neurosci. 2005 Jun;14(2):121-37. doi: 10.1080/096470490512580.

Contemporary opinions about Mary Walker: a shy pioneer of therapeutic neurology.

Neurology. 1998 Nov;51(5):1433-9. doi: 10.1212/wnl.51.5.1433.

Some discoveries on myasthenia gravis: the background.

Br Med J. 1973 Apr 7;2(5857):42-3. doi: 10.1136/bmj.2.5857.42.